No Cover Image

Journal article 439 views 49 downloads

Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial

Jeremy Segrott Orcid Logo, David Gillespie Orcid Logo, Mandy Lau Orcid Logo, Jo Holliday Orcid Logo, Simon Murphy Orcid Logo, David Foxcroft Orcid Logo, Kerenza Hood Orcid Logo, Jonathan Scourfield Orcid Logo, Ceri Phillips, Zoe Roberts, Heather Rothwell, Claire Hurlow, Laurence Moore Orcid Logo

BMJ Open, Volume: 12, Issue: 2, Start page: e049647

Swansea University Authors: Ceri Phillips, Claire Hurlow

  • 60738.pdf

    PDF | Version of Record

    © Author(s) (or their employer(s)) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license

    Download (1.58MB)

Check full text

DOI (Published version): 10.1136/bmjopen-2021-049647

Abstract

Objectives The Strengthening Families Programme 10–14 (SFP10-14) is a USA-developed universal group-based intervention aiming to prevent substance misuse by strengthening protective factors within the family. This study evaluated a proportionate universal implementation of the adapted UK version (SF...

Full description

Published in: BMJ Open
ISSN: 2044-6055 2044-6055
Published: BMJ 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa60738
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2022-08-05T10:33:33Z
last_indexed 2023-01-28T04:11:29Z
id cronfa60738
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><datestamp>2023-01-27T10:13:06.5918672</datestamp><bib-version>v2</bib-version><id>60738</id><entry>2022-08-05</entry><title>Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10&#x2013;14 year-olds: a pragmatic randomised controlled trial</title><swanseaauthors><author><sid>932c7a406ab4b6e4a881d422ca03c289</sid><firstname>Ceri</firstname><surname>Phillips</surname><name>Ceri Phillips</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b43341721b92e9860672c44bbf382b17</sid><ORCID/><firstname>Claire</firstname><surname>Hurlow</surname><name>Claire Hurlow</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-08-05</date><deptcode>FGMHL</deptcode><abstract>Objectives The Strengthening Families Programme 10&#x2013;14 (SFP10-14) is a USA-developed universal group-based intervention aiming to prevent substance misuse by strengthening protective factors within the family. This study evaluated a proportionate universal implementation of the adapted UK version (SFP10-14UK) which brought together families identified as likely/not likely to experience/present challenges within a group setting.Design Pragmatic cluster-randomised controlled effectiveness trial, with families as the unit of randomisation and embedded process and economic evaluations.Setting The study took place in seven counties of Wales, UK.Participants 715 families (919 parents/carers, 931 young people) were randomised.Interventions Families randomised to the intervention arm received the SFP10-14 comprising seven weekly sessions. Families in intervention and control arms received existing services as normal.Outcome measures Primary outcomes were the number of occasions young people reported drinking alcohol in the last 30 days; and drunkenness during the same period, dichotomised as &#x2018;never&#x2019; and &#x2018;1&#x2013;2 times or more&#x2019;. Secondary outcomes examined alcohol/tobacco/substance behaviours including: cannabis use; weekly smoking (validated by salivary cotinine measures); age of alcohol initiation; frequency of drinking &gt;5 drinks in a row; frequency of different types of alcoholic drinks; alcohol-related problems. Retention: primary analysis included 746 young people (80.1%) (alcohol consumption) and 732 young people (78.6%) (drunkenness).Results There was no evidence of statistically significant between-group differences 2 years after randomisation for primary outcomes (young people&#x2019;s alcohol consumption in the last 30 days adjusted OR=1.11, 95% CI 0.72 to 1.71, p=0.646; drunkenness in the last 30 days adjusted OR=1.46, 95% CI 0.83 to 2.55, p=0.185). There were no statistically significant between-group differences for other substance use outcomes, or those relating to well-being/stress, and emotional/behavioural problems.Conclusions Previous evidence of effectiveness was not replicated. Findings highlight the importance of evaluating interventions when they are adapted for new settings.</abstract><type>Journal Article</type><journal>BMJ Open</journal><volume>12</volume><journalNumber>2</journalNumber><paginationStart>e049647</paginationStart><paginationEnd/><publisher>BMJ</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2044-6055</issnPrint><issnElectronic>2044-6055</issnElectronic><keywords/><publishedDay>21</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-02-21</publishedDate><doi>10.1136/bmjopen-2021-049647</doi><url/><notes/><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>Funding of &#xA3;2.1 million from the National Prevention Research Initiative, managed by the Medical Research Council (award G0802128), included approximately &#xA3;650 000 implementation costs. The NPRI funding partners are Alzheimer&#x2019;s Research Trust; Alzheimer&#x2019;s Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; the Stroke Association; Welsh Government; and World Cancer Research Fund. A representative from the study funders was a member of the trial&#x2019;s independent trial steering committee. The Welsh Government provided approximately &#xA3;675 000 of partnership funding to cover the cost of implementation in three trial areas, and the associated training and support provided by the Cardiff Strengthening Families Programme team. Further support from the Welsh Government provided &#xA3;208 000 to cover programme delivery in six trial sites from August 2011 to July 2012. The Cardiff Strengthening Families Programme team also provided financial support for programme delivery and trial recruitment in schools. At the time of the study, DECIPHer was a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (RES-590-28-0005), Medical Research Council, the Welsh Government and the Wellcome Trust (WT087640MA), under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. DECIPHer funding has supported JSe and JH&#x2019;s input into the trial. The centre is now funded by the Welsh Government through Health and Care Research Wales. LM is supported by the Medical Research Council (MC_UU_00022/1) and the Chief Scientist Office (SPHSU16). The Centre for Trials Research is funded by Health and Care Research Wales and Cancer Research UK.</funders><projectreference/><lastEdited>2023-01-27T10:13:06.5918672</lastEdited><Created>2022-08-05T11:27:14.3401890</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Health and Social Care - Healthcare Science</level></path><authors><author><firstname>Jeremy</firstname><surname>Segrott</surname><orcid>0000-0001-6215-0870</orcid><order>1</order></author><author><firstname>David</firstname><surname>Gillespie</surname><orcid>0000-0002-6934-2928</orcid><order>2</order></author><author><firstname>Mandy</firstname><surname>Lau</surname><orcid>0000-0001-5894-570x</orcid><order>3</order></author><author><firstname>Jo</firstname><surname>Holliday</surname><orcid>0000-0003-4568-7320</orcid><order>4</order></author><author><firstname>Simon</firstname><surname>Murphy</surname><orcid>0000-0003-3589-3681</orcid><order>5</order></author><author><firstname>David</firstname><surname>Foxcroft</surname><orcid>0000-0001-9752-7527</orcid><order>6</order></author><author><firstname>Kerenza</firstname><surname>Hood</surname><orcid>0000-0002-5268-8631</orcid><order>7</order></author><author><firstname>Jonathan</firstname><surname>Scourfield</surname><orcid>0000-0001-6218-8158</orcid><order>8</order></author><author><firstname>Ceri</firstname><surname>Phillips</surname><order>9</order></author><author><firstname>Zoe</firstname><surname>Roberts</surname><order>10</order></author><author><firstname>Heather</firstname><surname>Rothwell</surname><order>11</order></author><author><firstname>Claire</firstname><surname>Hurlow</surname><orcid/><order>12</order></author><author><firstname>Laurence</firstname><surname>Moore</surname><orcid>0000-0003-2182-823x</orcid><order>13</order></author></authors><documents><document><filename>60738__24856__f99cf070d2ee4e0b8cd522dd6f943e42.pdf</filename><originalFilename>60738.pdf</originalFilename><uploaded>2022-08-05T11:31:42.0722662</uploaded><type>Output</type><contentLength>1655391</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>&#xA9; Author(s) (or their employer(s)) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs><OutputDur><Id>115</Id><IsDataAvailableOnline xsi:nil="true"/><DataNotAvailableOnlineReasonId xsi:nil="true"/><IsDurRestrictions xsi:nil="true"/><DurRestrictionReasonId xsi:nil="true"/><DurEmbargoDate xsi:nil="true"/></OutputDur></OutputDurs></rfc1807>
spelling 2023-01-27T10:13:06.5918672 v2 60738 2022-08-05 Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial 932c7a406ab4b6e4a881d422ca03c289 Ceri Phillips Ceri Phillips true false b43341721b92e9860672c44bbf382b17 Claire Hurlow Claire Hurlow true false 2022-08-05 FGMHL Objectives The Strengthening Families Programme 10–14 (SFP10-14) is a USA-developed universal group-based intervention aiming to prevent substance misuse by strengthening protective factors within the family. This study evaluated a proportionate universal implementation of the adapted UK version (SFP10-14UK) which brought together families identified as likely/not likely to experience/present challenges within a group setting.Design Pragmatic cluster-randomised controlled effectiveness trial, with families as the unit of randomisation and embedded process and economic evaluations.Setting The study took place in seven counties of Wales, UK.Participants 715 families (919 parents/carers, 931 young people) were randomised.Interventions Families randomised to the intervention arm received the SFP10-14 comprising seven weekly sessions. Families in intervention and control arms received existing services as normal.Outcome measures Primary outcomes were the number of occasions young people reported drinking alcohol in the last 30 days; and drunkenness during the same period, dichotomised as ‘never’ and ‘1–2 times or more’. Secondary outcomes examined alcohol/tobacco/substance behaviours including: cannabis use; weekly smoking (validated by salivary cotinine measures); age of alcohol initiation; frequency of drinking >5 drinks in a row; frequency of different types of alcoholic drinks; alcohol-related problems. Retention: primary analysis included 746 young people (80.1%) (alcohol consumption) and 732 young people (78.6%) (drunkenness).Results There was no evidence of statistically significant between-group differences 2 years after randomisation for primary outcomes (young people’s alcohol consumption in the last 30 days adjusted OR=1.11, 95% CI 0.72 to 1.71, p=0.646; drunkenness in the last 30 days adjusted OR=1.46, 95% CI 0.83 to 2.55, p=0.185). There were no statistically significant between-group differences for other substance use outcomes, or those relating to well-being/stress, and emotional/behavioural problems.Conclusions Previous evidence of effectiveness was not replicated. Findings highlight the importance of evaluating interventions when they are adapted for new settings. Journal Article BMJ Open 12 2 e049647 BMJ 2044-6055 2044-6055 21 2 2022 2022-02-21 10.1136/bmjopen-2021-049647 COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University Funding of £2.1 million from the National Prevention Research Initiative, managed by the Medical Research Council (award G0802128), included approximately £650 000 implementation costs. The NPRI funding partners are Alzheimer’s Research Trust; Alzheimer’s Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; the Stroke Association; Welsh Government; and World Cancer Research Fund. A representative from the study funders was a member of the trial’s independent trial steering committee. The Welsh Government provided approximately £675 000 of partnership funding to cover the cost of implementation in three trial areas, and the associated training and support provided by the Cardiff Strengthening Families Programme team. Further support from the Welsh Government provided £208 000 to cover programme delivery in six trial sites from August 2011 to July 2012. The Cardiff Strengthening Families Programme team also provided financial support for programme delivery and trial recruitment in schools. At the time of the study, DECIPHer was a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (RES-590-28-0005), Medical Research Council, the Welsh Government and the Wellcome Trust (WT087640MA), under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. DECIPHer funding has supported JSe and JH’s input into the trial. The centre is now funded by the Welsh Government through Health and Care Research Wales. LM is supported by the Medical Research Council (MC_UU_00022/1) and the Chief Scientist Office (SPHSU16). The Centre for Trials Research is funded by Health and Care Research Wales and Cancer Research UK. 2023-01-27T10:13:06.5918672 2022-08-05T11:27:14.3401890 Faculty of Medicine, Health and Life Sciences School of Health and Social Care - Healthcare Science Jeremy Segrott 0000-0001-6215-0870 1 David Gillespie 0000-0002-6934-2928 2 Mandy Lau 0000-0001-5894-570x 3 Jo Holliday 0000-0003-4568-7320 4 Simon Murphy 0000-0003-3589-3681 5 David Foxcroft 0000-0001-9752-7527 6 Kerenza Hood 0000-0002-5268-8631 7 Jonathan Scourfield 0000-0001-6218-8158 8 Ceri Phillips 9 Zoe Roberts 10 Heather Rothwell 11 Claire Hurlow 12 Laurence Moore 0000-0003-2182-823x 13 60738__24856__f99cf070d2ee4e0b8cd522dd6f943e42.pdf 60738.pdf 2022-08-05T11:31:42.0722662 Output 1655391 application/pdf Version of Record true © Author(s) (or their employer(s)) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license true eng https://creativecommons.org/licenses/by/4.0/ 115
title Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial
spellingShingle Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial
Ceri Phillips
Claire Hurlow
title_short Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial
title_full Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial
title_fullStr Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial
title_full_unstemmed Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial
title_sort Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10–14 year-olds: a pragmatic randomised controlled trial
author_id_str_mv 932c7a406ab4b6e4a881d422ca03c289
b43341721b92e9860672c44bbf382b17
author_id_fullname_str_mv 932c7a406ab4b6e4a881d422ca03c289_***_Ceri Phillips
b43341721b92e9860672c44bbf382b17_***_Claire Hurlow
author Ceri Phillips
Claire Hurlow
author2 Jeremy Segrott
David Gillespie
Mandy Lau
Jo Holliday
Simon Murphy
David Foxcroft
Kerenza Hood
Jonathan Scourfield
Ceri Phillips
Zoe Roberts
Heather Rothwell
Claire Hurlow
Laurence Moore
format Journal article
container_title BMJ Open
container_volume 12
container_issue 2
container_start_page e049647
publishDate 2022
institution Swansea University
issn 2044-6055
2044-6055
doi_str_mv 10.1136/bmjopen-2021-049647
publisher BMJ
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str School of Health and Social Care - Healthcare Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Health and Social Care - Healthcare Science
document_store_str 1
active_str 0
description Objectives The Strengthening Families Programme 10–14 (SFP10-14) is a USA-developed universal group-based intervention aiming to prevent substance misuse by strengthening protective factors within the family. This study evaluated a proportionate universal implementation of the adapted UK version (SFP10-14UK) which brought together families identified as likely/not likely to experience/present challenges within a group setting.Design Pragmatic cluster-randomised controlled effectiveness trial, with families as the unit of randomisation and embedded process and economic evaluations.Setting The study took place in seven counties of Wales, UK.Participants 715 families (919 parents/carers, 931 young people) were randomised.Interventions Families randomised to the intervention arm received the SFP10-14 comprising seven weekly sessions. Families in intervention and control arms received existing services as normal.Outcome measures Primary outcomes were the number of occasions young people reported drinking alcohol in the last 30 days; and drunkenness during the same period, dichotomised as ‘never’ and ‘1–2 times or more’. Secondary outcomes examined alcohol/tobacco/substance behaviours including: cannabis use; weekly smoking (validated by salivary cotinine measures); age of alcohol initiation; frequency of drinking >5 drinks in a row; frequency of different types of alcoholic drinks; alcohol-related problems. Retention: primary analysis included 746 young people (80.1%) (alcohol consumption) and 732 young people (78.6%) (drunkenness).Results There was no evidence of statistically significant between-group differences 2 years after randomisation for primary outcomes (young people’s alcohol consumption in the last 30 days adjusted OR=1.11, 95% CI 0.72 to 1.71, p=0.646; drunkenness in the last 30 days adjusted OR=1.46, 95% CI 0.83 to 2.55, p=0.185). There were no statistically significant between-group differences for other substance use outcomes, or those relating to well-being/stress, and emotional/behavioural problems.Conclusions Previous evidence of effectiveness was not replicated. Findings highlight the importance of evaluating interventions when they are adapted for new settings.
published_date 2022-02-21T04:19:06Z
_version_ 1763754268284682240
score 11.013148

Similar Items